These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16259544)

  • 21. Emerging evidence for the use of atypical antipsychotics in borderline personality disorder.
    Grootens KP; Verkes RJ
    Pharmacopsychiatry; 2005 Jan; 38(1):20-3. PubMed ID: 15706462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two weeks' quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder: a naturalistic study with drug plasma levels.
    Mauri MC; Volonteri LS; Fiorentini A; Pirola R; Bareggi SR
    Expert Opin Pharmacother; 2007 Oct; 8(14):2207-13. PubMed ID: 17927477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of borderline personality disorder with risperidone.
    Rocca P; Marchiaro L; Cocuzza E; Bogetto F
    J Clin Psychiatry; 2002 Mar; 63(3):241-4. PubMed ID: 11926724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial.
    McConville B; Carrero L; Sweitzer D; Potter L; Chaney R; Foster K; Sorter M; Friedman L; Browne K
    J Child Adolesc Psychopharmacol; 2003; 13(1):75-82. PubMed ID: 12804128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
    Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A
    J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asenapine in the management of impulsivity and aggressiveness in bipolar disorder and comorbid borderline personality disorder: an open-label uncontrolled study.
    Aguglia A; Mineo L; Rodolico A; Signorelli MS; Aguglia E
    Int Clin Psychopharmacol; 2018 May; 33(3):121-130. PubMed ID: 29189421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open-label trial of divalproex extended-release in the treatment of borderline personality disorder.
    Simeon D; Baker B; Chaplin W; Braun A; Hollander E
    CNS Spectr; 2007 Jun; 12(6):439-43. PubMed ID: 17545954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy.
    Hamner MB; Deitsch SE; Brodrick PS; Ulmer HG; Lorberbaum JP
    J Clin Psychopharmacol; 2003 Feb; 23(1):15-20. PubMed ID: 12544370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hostility and childhood sexual abuse as predictors of suicidal behaviour in Borderline Personality Disorder.
    Ferraz L; Portella MJ; Vállez M; Gutiérrez F; Martín-Blanco A; Martín-Santos R; Subirà S
    Psychiatry Res; 2013 Dec; 210(3):980-5. PubMed ID: 23993466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
    Barzman DH; DelBello MP; Adler CM; Stanford KE; Strakowski SM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
    Bowden CL; Grunze H; Mullen J; Brecher M; Paulsson B; Jones M; Vågerö M; Svensson K
    J Clin Psychiatry; 2005 Jan; 66(1):111-21. PubMed ID: 15669897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olanzapine versus haloperidol in the management of borderline personality disorder: a randomized double-blind trial.
    Shafti SS; Shahveisi B
    J Clin Psychopharmacol; 2010 Feb; 30(1):44-7. PubMed ID: 20075647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
    Liebowitz M; Lam RW; Lepola U; Datto C; Sweitzer D; Eriksson H
    Depress Anxiety; 2010 Oct; 27(10):964-76. PubMed ID: 20734365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
    Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
    J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study.
    Bauer M; Pretorius HW; Constant EL; Earley WR; Szamosi J; Brecher M
    J Clin Psychiatry; 2009 Apr; 70(4):540-9. PubMed ID: 19358791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
    Lee KU; Jeon YW; Lee HK; Jun TY
    Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis.
    Sajatovic M; Mullen JA; Sweitzer DE
    J Clin Psychiatry; 2002 Dec; 63(12):1156-63. PubMed ID: 12523876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning.
    Kinon BJ; Noordsy DL; Liu-Seifert H; Gulliver AH; Ascher-Svanum H; Kollack-Walker S
    J Clin Psychopharmacol; 2006 Oct; 26(5):453-61. PubMed ID: 16974184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.
    Tariot PN; Schneider L; Katz IR; Mintzer JE; Street J; Copenhaver M; Williams-Hughes C
    Am J Geriatr Psychiatry; 2006 Sep; 14(9):767-76. PubMed ID: 16905684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.
    McManus DQ; Arvanitis LA; Kowalcyk BB
    J Clin Psychiatry; 1999 May; 60(5):292-8. PubMed ID: 10362435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.